oxymetazoline has been researched along with Blepharospasm in 1 studies
Oxymetazoline: A direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1251)
oxymetazoline : A member of the class of phenols that is 2,4-dimethylphenol which is substituted at positions 3 and 6 by 4,5-dihydro-1H-imidazol-2-ylmethyl and tert-butyl groups, respectively. A direct-acting sympathomimetic with marked alpha-adrenergic activity, it is a vasoconstrictor that is used (generally as the hydrochloride salt) to relieve nasal congestion.
Blepharospasm: Excessive winking; tonic or clonic spasm of the orbicularis oculi muscle.
Excerpt | Relevance | Reference |
---|---|---|
"Administering botulinum toxin for the treatment of blepharospasm in patients A and B yielded the expected results; adding oxymetazoline hydrochloride ophthalmic solution (0." | 8.12 | Oxymetazoline hydrochloride ophthalmic solution, 0.1%, boosts the effects of botulinum toxin on blepharospasm: a case series. ( Song, A; Song, J; Song, M; Sung, J, 2022) |
"Administering botulinum toxin for the treatment of blepharospasm in patients A and B yielded the expected results; adding oxymetazoline hydrochloride ophthalmic solution (0." | 4.12 | Oxymetazoline hydrochloride ophthalmic solution, 0.1%, boosts the effects of botulinum toxin on blepharospasm: a case series. ( Song, A; Song, J; Song, M; Sung, J, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Sung, J | 1 |
Song, A | 1 |
Song, M | 1 |
Song, J | 1 |
1 other study available for oxymetazoline and Blepharospasm
Article | Year |
---|---|
Oxymetazoline hydrochloride ophthalmic solution, 0.1%, boosts the effects of botulinum toxin on blepharospasm: a case series.
Topics: Blepharoptosis; Blepharospasm; Botulinum Toxins; Botulinum Toxins, Type A; Female; Humans; Middle Ag | 2022 |